Product NDC: | 0121-4727 |
Proprietary Name: | Ranitidine |
Non Proprietary Name: | Ranitidine |
Active Ingredient(s): | 15 mg/mL & nbsp; Ranitidine |
Administration Route(s): | ORAL |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0121-4727 |
Labeler Name: | Pharmaceutical Associates, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077405 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090919 |
Package NDC: | 0121-4727-10 |
Package Description: | 4 TRAY in 1 CASE (0121-4727-10) > 10 CUP, UNIT-DOSE in 1 TRAY > 10 mL in 1 CUP, UNIT-DOSE |
NDC Code | 0121-4727-10 |
Proprietary Name | Ranitidine |
Package Description | 4 TRAY in 1 CASE (0121-4727-10) > 10 CUP, UNIT-DOSE in 1 TRAY > 10 mL in 1 CUP, UNIT-DOSE |
Product NDC | 0121-4727 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ranitidine |
Dosage Form Name | SOLUTION |
Route Name | ORAL |
Start Marketing Date | 20090919 |
Marketing Category Name | ANDA |
Labeler Name | Pharmaceutical Associates, Inc. |
Substance Name | RANITIDINE |
Strength Number | 15 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |